Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q8WX
|
|||
| Former ID |
DIB002297
|
|||
| Drug Name |
AM-101
|
|||
| Indication | Tinnitus [ICD-11: MC41; ICD-10: H93.1] | Phase 3 | [1] | |
| Company |
Auris Medical AG
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C13H17Cl2NO
|
|||
| Canonical SMILES |
CNC1(CCCCC1=O)C2=CC=CC=C2Cl.Cl
|
|||
| InChI |
1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H/t13-;/m0./s1
|
|||
| InChIKey |
VCMGMSHEPQENPE-ZOWNYOTGSA-N
|
|||
| CAS Number |
CAS 33643-47-9
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:60800
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01803646) AM-101 in the Treatment of Acute Tinnitus 2. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.